MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 129 filers reported holding MERSANA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 4.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,173 | -61.4% | 17,459 | 0.0% | 0.00% | – |
| Q2 2023 | $57,440 | +14.1% | 17,459 | +42.6% | 0.00% | – |
| Q1 2023 | $50,335 | -29.9% | 12,247 | 0.0% | 0.00% | – |
| Q4 2022 | $71,767 | +46.5% | 12,247 | +68.6% | 0.00% | – |
| Q3 2022 | $49,000 | +44.1% | 7,262 | 0.0% | 0.00% | – |
| Q2 2022 | $34,000 | +17.2% | 7,262 | 0.0% | 0.00% | – |
| Q1 2022 | $29,000 | -52.5% | 7,262 | -26.1% | 0.00% | – |
| Q4 2021 | $61,000 | -35.8% | 9,826 | -2.6% | 0.00% | -100.0% |
| Q3 2021 | $95,000 | -30.7% | 10,092 | +0.1% | 0.00% | 0.0% |
| Q2 2021 | $137,000 | -14.9% | 10,081 | +1.3% | 0.00% | 0.0% |
| Q1 2021 | $161,000 | -16.6% | 9,947 | +37.0% | 0.00% | 0.0% |
| Q4 2020 | $193,000 | +82.1% | 7,262 | +28.0% | 0.00% | 0.0% |
| Q3 2020 | $106,000 | -20.3% | 5,674 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $133,000 | – | 5,674 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 796,458 | $4,564,000 | 3.47% |
| NEA Management Company, LLC | 11,963,649 | $68,552,000 | 3.24% |
| Sarissa Capital Management LP | 3,750,000 | $21,487,000 | 1.78% |
| VHCP Management III, LLC | 1,561,389 | $8,947,000 | 1.78% |
| VHCP Management II, LLC | 922,514 | $5,286,000 | 1.39% |
| Ghost Tree Capital, LLC | 800,000 | $4,584,000 | 0.87% |
| BVF INC/IL | 1,180,553 | $6,765,000 | 0.51% |
| Sio Capital Management, LLC | 166,250 | $953,000 | 0.23% |
| Rock Springs Capital Management LP | 1,233,000 | $7,065,000 | 0.22% |
| DAFNA Capital Management LLC | 108,463 | $621,000 | 0.21% |